Loading clinical trials...

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

NCT07239167•National Taiwan University Hospital

Summary

This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment. Participants underwent a battery of measurements and questionnaires, including height, weight, waist circumference, blood pressure, blood tests, and questionnaires addressing diet, exercise, stress, sleep, and psychological well-being.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Adults aged 18 years or older, regardless of gender.
•2. Body mass index (BMI) ≥ 27 kg/m², or ≥ 24 kg/m² with one or more obesity-related comorbidities.
•3. Willing to undergo any form of weight loss intervention.
•4. Able to read and understand Chinese, willing to complete questionnaires, blood tests, and follow-up follow-up.
•5. Voluntarily consent to participate and be willing to complete the subject consent form.

Exclusion Criteria

•1. Pregnant or breastfeeding women.
•2. Individuals with significant mental illness (e.g., schizophrenia, severe depression) or cognitive impairment that may affect their ability to consent or cooperate with the study.
•3. Individuals with severe organ dysfunction (e.g., end-stage renal disease, cirrhosis, congestive heart failure, etc.).
•4. Individuals taking medications that significantly affect their weight (e.g., long-term steroids or antipsychotics) and cannot be discontinued.
•5. Individuals deemed unsuitable for participation in this study by the study leader (e.g., individuals who are expected to be unable to complete follow-up).

Locations (1)

No.7, Chung Shan S. Rd.（Zhongshan S. Rd.）

Taipei, Zhongzheng Dist, Taiwan

Key Dates

Start Date

June 5, 2025

Primary Completion Date

April 8, 2027

Completion Date

May 5, 2035

Last Updated

January 9, 2026

Enrollment

500

ESTIMATED participants

Conditions

Obesity & OverweightWeight LossMetabolic SyndromeMetabolic Dysfunction-Associated SteatohepatitisObesity (Disorder)

Protein Supplementation Intervention on Body Weight

NCT06989203

ObesityWeight Loss+1 more

View study

RECRUITINGNA

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

NCT07237750

Overweight and/or ObesityMetabolic Syndrome+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

Inclusion Criteria

Exclusion Criteria

Protein Supplementation Intervention on Body Weight

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Effects of Cranberry on Gut and Metabolic Health

Personalizing Financial Incentives

Adherence to an Exercise Program and Pre- and Post-Changes After Bariatric Surgery

Exercise and Dietary Lifestyle Intervention on Reducing Atrial Fibrillation Burden, Cardiac and Body Fat Mass.